The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Lovelace Biomedical Research Institute a single award indefinite delivery contract with a potential value of $100 million. The contract aims to procure biological animal model and medical countermeasure development services through flexible contracting solutions. Lovelace Biomedical will utilize its expertise to assist the agency in oversight of its Indefinite Delivery Indefinite...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to SRI International of Menlo Park, California. The contract aims to develop animal models for the Biomedical Advanced Research and Development Authority's countermeasure programs against radiological and nuclear threats. Under the contract, SRI International was issued a $309,727...
This indefinite delivery contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to the Lovelace Biomedical Research Institute. The $45,000,000 single-award contract runs through July 31, 2025 and is for the development of animal models to evaluate medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery contract to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract has a potential value of $100 million and a period of performance through September 2027 to provide biological animal model and medical countermeasure development support. Two associated delivery orders have been...
The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...
The Lovelace Biomedical Research Institute has been awarded an indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. With a potential value of $150 million, this single award IDV enables NIAID to procure preclinical product development services for candidate products from Lovelace through July 2023. Under the IDV, Lovelace has received a $486,301 cost-plus-fixed-fee delivery order to transfer, validate and qualify bioanalytical...
The Board of Trustees of the University of Illinois has been awarded a single-award indefinite delivery contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. With a potential value of $100 million and a period of performance through September 2027, this contract provides for animal model development services in support of the Chemical, Radiological, and Nuclear program. A cost-plus-fixed-fee delivery order valued at $2.19 million...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The Federal Supply Schedule contract GS07F6002R was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, a not-for-profit contract research organization. This multiple award IDV provides a range of preclinical research services to federal agencies such as the NIH, NIAID, NCATS, BARDA, and Leidos. Through task orders under this contract, LBERI performs activities like efficacy testing of HIV therapeutics,...